New imaging agent could sharpen lung nodule diagnosis
NCT ID NCT07448441
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test a new imaging drug called Trap-(FAPI)3 to see if it can improve PET scans for people with lung nodules. The goal is to better tell if a nodule is cancer and how far it has spread. About 50 adults with lung nodules found on scans will receive the drug and then have a PET/CT scan. The study will measure how accurate the imaging is compared to standard methods.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG NODULES are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Nuclear Medicine, Daping Hospital of Army Medical University
Chongqing, Chongqing Municipality, 400010, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Pre-Procedure painkiller ease the pain of lung nodule marking?
- Blood test may spot lung cancer sooner in High-Risk patients
- Acupuncture needles aim to boost lung recovery after surgery
- Robot battle: which bronchoscope best snags lung nodules?
- Robot bronchoscopy could spot lung cancer earlier
- 2000 volunteers needed to help spot lung cancer earlier